Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

World’s most populous country gains access to Medtronic’s newest TAVR valve
Medtronic developed the self-expanding Evolut FX+ TAVR system with improved coronary access in mind. The FDA-approved device has now officially launched in India.
New registry helps hospitals expand outpatient services for heart patients
The initiation of the ACC Ambulatory Surgical Center Registry comes at a time when hospitals are expanding their structural heart programs. The registry is providing valuable details about which patients should stay at the hospital and which can be treated in an outpatient setting.
FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Joysticks recalled after power wheelchairs move on their own, injuring a patient
The U.S. Food and Drug Administration announced a recall of Mo-Vis BVBA joysticks after a faulty firmware version was linked to the malfunction. Users will need to have their devices upgraded.
FDA approves nasal spray for edema associated with congestive heart failure
The newly approved intranasal loop diuretic can also be used to treat edema in patients with liver and kidney disease.

How cardiologists reacted to the rapid rise and fall of BVS

The bioresorbable vascular scaffold, once an exciting prospect for cardiologists, saw a unique rise and fall in popularity within a year of its introduction to the CV market.

Challenges of Infective Endocarditis: The Opioid Crisis Hits Home & Cardiologists Can’t Go It Alone

As rates of infective endocarditis among intravenous drug users skyrocket, cardiologists are finding that treating the heart condition without addressing the disease of addiction contributes to readmissions and mortality.

‘Really Not Close’: TAVR Trumps SAVR in Two Trials of Low-risk Patients

Clinical trials presented at ACC.19 flipped the script on TAVR vs. SAVR.

Positive Projections: TAVR/TMVR Market Likely to Double by 2023

The global market for transcatheter treatment of the mitral and aortic valves is expected to increase from $4 billion to $8 billion in the next five years, but barriers exist.

Stop the Bleeding: Hemorrhagic Complications Gain Ground on Ischemia in Treating Patients with Arrhythmia

Atrial fibrillation patients with coronary artery disease pose a delicate balancing act for physicians. A growing awareness of bleeding vs. ischemic risks could soon lead to a steadier therapeutic response.

Going the Distance: Is Telestenting a New Path for PCI?

Telehealth enthusiasts are optimistic about telestenting’s potential to solve access-to-care issues but concede that significant obstacles must be overcome before it will be ready for prime time.

BioCardia receives clearance for AVANCE steerable catheter introducers

BioCardia’s AVANCE steerable introducer family has received FDA 510(k) clearance, the company announced May 8.

Study reveals patients don’t know much about their heart implants—but they want to

Research presented at the Heart Rhythm Society’s 40th annual scientific sessions in San Francisco May 7 suggests heart patients with implanted electronic devices know less about their therapies than they think they do.

Clinical

World’s most populous country gains access to Medtronic’s newest TAVR valve

New registry helps hospitals expand outpatient services for heart patients

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Joysticks recalled after power wheelchairs move on their own, injuring a patient

FDA approves nasal spray for edema associated with congestive heart failure